CureVac N.V. (FRA:5CV)
Germany · Delayed Price · Currency is EUR 4.698
+0.018 (0.38%)
Jul 17, 2025, 5:59 PM CET
CureVac Market Cap
CureVac has a market cap or net worth of €1.06 billion as of July 17, 2025. Its market cap has increased by 50.15% in one year.
Market Cap
1.06B
Enterprise Value
685.78M
Revenue
523.70M
Ranking
n/a
PE Ratio
5.85
Stock Price
€4.70
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 1.06B, a decrease of -87.29%. That is a compound annual growth rate of -34.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 1.05B | 42.00% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 51.39B |
| Merck KGaA | 48.02B |
| Bayer Aktiengesellschaft | 27.08B |
| Fresenius SE & Co. KGaA | 23.06B |
| Fresenius Medical Care AG | 13.61B |
| Sartorius Aktiengesellschaft | 13.14B |
| Fielmann Group AG | 4.80B |
| Carl Zeiss Meditec AG | 4.41B |